Vontobel Holding Ltd. Sells 2,974 Shares of Option Care Health, Inc. (NASDAQ:OPCH)

Vontobel Holding Ltd. lessened its position in Option Care Health, Inc. (NASDAQ:OPCHFree Report) by 22.6% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 10,194 shares of the company’s stock after selling 2,974 shares during the period. Vontobel Holding Ltd.’s holdings in Option Care Health were worth $343,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently made changes to their positions in OPCH. First Horizon Advisors Inc. bought a new position in shares of Option Care Health in the third quarter worth approximately $37,000. Headlands Technologies LLC lifted its stake in shares of Option Care Health by 5,796.7% in the third quarter. Headlands Technologies LLC now owns 1,769 shares of the company’s stock worth $57,000 after buying an additional 1,739 shares in the last quarter. IFP Advisors Inc lifted its stake in shares of Option Care Health by 20,350.0% in the third quarter. IFP Advisors Inc now owns 2,454 shares of the company’s stock worth $79,000 after buying an additional 2,442 shares in the last quarter. Fifth Third Bancorp lifted its stake in shares of Option Care Health by 219.6% in the third quarter. Fifth Third Bancorp now owns 2,723 shares of the company’s stock worth $88,000 after buying an additional 1,871 shares in the last quarter. Finally, International Assets Investment Management LLC lifted its stake in shares of Option Care Health by 1,513.7% in the fourth quarter. International Assets Investment Management LLC now owns 3,066 shares of the company’s stock worth $103,000 after buying an additional 2,876 shares in the last quarter. Institutional investors own 98.05% of the company’s stock.

Option Care Health Stock Up 0.6 %

Shares of Option Care Health stock opened at $30.59 on Wednesday. The company has a market cap of $5.32 billion, a price-to-earnings ratio of 20.81, a price-to-earnings-growth ratio of 1.77 and a beta of 1.22. The company’s 50 day moving average is $32.19 and its 200 day moving average is $31.53. Option Care Health, Inc. has a twelve month low of $24.23 and a twelve month high of $35.74. The company has a quick ratio of 1.33, a current ratio of 1.77 and a debt-to-equity ratio of 0.74.

Option Care Health (NASDAQ:OPCHGet Free Report) last issued its quarterly earnings data on Thursday, February 22nd. The company reported $0.32 earnings per share for the quarter, beating analysts’ consensus estimates of $0.29 by $0.03. Option Care Health had a net margin of 6.21% and a return on equity of 18.78%. The company had revenue of $1.12 billion for the quarter, compared to the consensus estimate of $1.09 billion. During the same quarter in the prior year, the firm earned $0.26 earnings per share. The firm’s revenue for the quarter was up 9.5% compared to the same quarter last year. Research analysts anticipate that Option Care Health, Inc. will post 1.13 EPS for the current year.

Insiders Place Their Bets

In other Option Care Health news, Director Harry M. Jansen Kraemer, Jr. purchased 35,000 shares of the firm’s stock in a transaction on Monday, February 26th. The shares were acquired at an average cost of $31.55 per share, for a total transaction of $1,104,250.00. Following the completion of the transaction, the director now owns 269,528 shares of the company’s stock, valued at $8,503,608.40. The acquisition was disclosed in a filing with the SEC, which is accessible through the SEC website. Insiders own 0.64% of the company’s stock.

Wall Street Analysts Forecast Growth

Several brokerages have recently issued reports on OPCH. Barrington Research upped their target price on shares of Option Care Health from $35.00 to $38.00 and gave the stock an “outperform” rating in a research note on Friday, February 23rd. Jefferies Financial Group increased their price objective on shares of Option Care Health from $36.00 to $38.00 and gave the company a “buy” rating in a research report on Monday, March 4th.

Get Our Latest Research Report on Option Care Health

About Option Care Health

(Free Report)

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.

Featured Stories

Want to see what other hedge funds are holding OPCH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Option Care Health, Inc. (NASDAQ:OPCHFree Report).

Institutional Ownership by Quarter for Option Care Health (NASDAQ:OPCH)

Receive News & Ratings for Option Care Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Option Care Health and related companies with MarketBeat.com's FREE daily email newsletter.